Business Description
Cengild Medical Bhd
ISIN : MYQ0243OO004
Compare
Compare
Traded in other countries / regions
0243.Malaysia IPO Date
2022-04-18Description
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.69 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.34 | |||||
| Interest Coverage | 24.15 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.61 | |||||
| Beneish M-Score | -1.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.8 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | 2.7 | |||||
| 3-Year Book Growth Rate | 99 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.48 | |||||
| 9-Day RSI | 47.04 | |||||
| 14-Day RSI | 49.34 | |||||
| 6-1 Month Momentum % | -14.29 | |||||
| 12-1 Month Momentum % | -20.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.48 | |||||
| Quick Ratio | 5.37 | |||||
| Cash Ratio | 4.79 | |||||
| Days Inventory | 17.54 | |||||
| Days Sales Outstanding | 32.36 | |||||
| Days Payable | 35.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.74 | |||||
| Dividend Payout Ratio | 0.53 | |||||
| Forward Dividend Yield % | 2.74 | |||||
| 5-Year Yield-on-Cost % | 2.74 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 4.54 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.56 | |||||
| Operating Margin % | 18.37 | |||||
| Net Margin % | 16.05 | |||||
| FCF Margin % | -5.05 | |||||
| ROE % | 10.44 | |||||
| ROA % | 8.48 | |||||
| ROIC % | 26.49 | |||||
| ROC (Joel Greenblatt) % | 65.4 | |||||
| ROCE % | 14.36 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.33 | |||||
| PE Ratio without NRI | 18.33 | |||||
| Price-to-Owner-Earnings | 18.1 | |||||
| PEG Ratio | 0.82 | |||||
| PS Ratio | 3.24 | |||||
| PB Ratio | 2.04 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| Price-to-Operating-Cash-Flow | 17.19 | |||||
| EV-to-EBIT | 8.57 | |||||
| EV-to-EBITDA | 6.71 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-FCF | -41.02 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.95 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.06 | |||||
| Price-to-Net-Cash | 3.44 | |||||
| Earnings Yield (Greenblatt) % | 11.67 | |||||
| FCF Yield % | -1.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cengild Medical Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 71.539 | ||
| EPS (TTM) (RM) | 0.015 | ||
| Beta | 0 | ||
| Volatility % | 21.28 | ||
| 14-Day RSI | 49.34 | ||
| 14-Day ATR (RM) | 0.008374 | ||
| 20-Day SMA (RM) | 0.283 | ||
| 12-1 Month Momentum % | -20.59 | ||
| 52-Week Range (RM) | 0.24 - 0.345 | ||
| Shares Outstanding (Mil) | 832.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cengild Medical Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cengild Medical Bhd Stock Events
| Event | Date | Price(RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cengild Medical Bhd Frequently Asked Questions
What is Cengild Medical Bhd(XKLS:0243)'s stock price today?
The current price of XKLS:0243 is RM0.28. The 52 week high of XKLS:0243 is RM0.35 and 52 week low is RM0.24.
When is next earnings date of Cengild Medical Bhd(XKLS:0243)?
The next earnings date of Cengild Medical Bhd(XKLS:0243) is .
Does Cengild Medical Bhd(XKLS:0243) pay dividends? If so, how much?
The Dividend Yield %  of Cengild Medical Bhd(XKLS:0243) is 2.74% (As of Today), Highest Dividend Payout Ratio of Cengild Medical Bhd(XKLS:0243) was 0.54. The lowest was 0.44. And the median was 0.49. The  Forward Dividend Yield % of Cengild Medical Bhd(XKLS:0243) is 2.74%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers